 |
| BMIX Completes Purchase WWIO Interview Excites PZOO Pops on News |
|
 Hot Stock to Watch
|
Company: Brazil Minerals Inc. (OTCQB: BMIX)
|
End of Day:
Price: 0.0451
Change (%): - 0.0009 (1.96)
Volume: 78,364 |
 |
Brazil Minerals, Inc. Now Owns 100% of the Duas Barras Diamond & Gold Mine
BELO HORIZONTE, BRAZIL-(Marketwired - Oct 7, 2014) - Brazil Minerals, Inc. (OTCQB: BMIX), (the “Company” or “BMIX”), a U.S. holding company with revenues from sales of polished and rough diamonds as well as gold bars, all from its own production, announced today that it had purchased and formally received title to the remainder of Mineração Duas Barras Ltda. (“MDB”) that it did not own before. MDB is the first operational, revenue-generating business owned fully by BMIX.
Marc Fogassa, Chairman and CEO of BMIX, commented: “Our original goal had been to finish the acquisition of 100% of MDB by the end of 2014. I am delighted that we were able to expedite this plan and beat it by three months. MDB under our management team supervision has gone from a distressed asset to a producer of polished and rough diamonds, gold bars, and sand in the course of about a year and half. MDB is the core basis for our expanding diamond and gold center in northern Minas Gerais in Brazil.”
Continue Reading
|
 Yesterday's Top Performer
|
Company: Wowio Inc (Pink Sheets: WWIO)
|
End of Day:
Price: 0.095
Change (%): + 0.045 (90.00)
Volume: 93,805 |
 |
A New Audio Interview With Brian Altounian, CEO of WOWIO, Inc., is Now at SmallCapVoice.com
AUSTIN, Texas, Oct. 7, 2014 (GLOBE NEWSWIRE) - SmallCapVoice.com, Inc. (SCV) announced today that a new audio interview with Wowio, Inc. (OTCQB:WWIO), a technology development and digital media company with a patented process and a proprietary mobile ad-delivery platform that will disrupt the eBook distribution landscape, is now available. The interview can be heard at http://smallcapvoice.com/blog/10-3-14-smallcapvoice-interview-with-wowio-inc-wwio
Brian Altounian, CEO of WOWIO, called into SmallCapVoice.com to provide the listening audience with a comprehensive overview of the Wowio history, the highlights on the amazing year for the Company so far here in 2014, as well as his own candid insights into the goals for the Company in the remainder of 2014 and beyond.
Continue Reading |
Other Small Cap News
|
Company: Pazoo, Inc. (OTCQB: PZOO) |
Visitor Duration Dramatically Increases on Pazoo.com
WHIPPANY, NJ--(Marketwired - Oct 7, 2014) - Pazoo, Inc. (OTCQB: PZOO) (German WKN#: A1J3DK) is pleased to report that the average time spent on the website by a visitor has soared in the past two months, reaching more than 32 minutes as of the recent past. This is a dramatic increase from early August where we reported time spent on the website in the low 20 minute range, as reported by Google Analytics.
Pazoo has been in the process of changing website platforms and technologies. Because of these improvements, overall traffic is down to the website. The total number of visitors to the website decreased while we were making these technology improvements to the site, however, having visitors spend dramatically more time on the website will lead to an increase in profitability moving forward. We believe this additional time spent on the site is due to our newly enhanced video content, as well as our ever-increasing panel of writers, bloggers, and health and wellness experts who post new content on pazoo.com on a daily basis.
Continue Reading
|
Company: Generex Biotechnology Corporation (OTCBB: GNBT)
|
Generex Clarifies Utility of Antigen Express Technology for Potential Ebola Vaccine
WORCESTER, Mass. and TORONTO, Oct. 7, 2014 /PRNewswire/ -- Generex Biotechnology Corporation (OTCBB: GNBT) today responded to a recent article posted to the Seeking Alpha website (http://seekingalpha.com/article/2533015-with-ebola-looming-when-will-the-defense-department-get-around-to-generex) regarding the need for an Ebola vaccine and the importance of providing funding for small companies with technologies applicable to such an endeavor. Generex is the parent company of Antigen Express, Inc., which focuses on the development of synthetic peptide vaccines for significant unmet medical needs.
Antigen Express has previously published its work on the development of a vaccine for potentially pandemic viruses such as the H5N1 (avian flu) and H1N1 (swine flu) influenza strains. The advantage of the technology is that it entails entirely synthetic production methods, which are rapid, cost effective, and flexible. The vaccine is produced using a small fragment derived from a target protein modified to ensure activation of CD4+ T helper cells. This cell type is critical in the generation of an effective immune response to a novel agent.
Continue Reading |
Market News
|
By Kate Gibson: CNBC
|
Dow falls triple-digits as European worries hit
U.S. stocks fell sharply on Tuesday, extending losses into a second session, as investors fretted increased signals of slowing growth in Europe and pondered the impact on quarterly earnings from U.S. corporations.
"We are concerned about ongoing slowness in Europe as we're about to head into earnings," said Art Hogan, chief market strategist at Wunderlich Securities.
The International Monetary Fund downgraded its global growth forecast for this year and 2015, with the organization that represents 188 countries now projecting world growth to come in at 3.3 percent in 2014, down 0.1 percent from its July forecast. Next year, it expects growth of 3.8 percent.
Continue Reading
|
By Peter C. Kenny: Yahoo Finance Contributor
|
The moment of truth, Q3 earnings season, has arrived for U.S. equities
The moment of truth has arrived this morning. Earnings Season. As we have discussed, recent economic data has proved a positive narrative for markets but without earnings that narrative lacks the confirmation that is essential for any decisive move higher from here for US equities. My sense is that we will indeed get the earnings quality and guidance that provides a flight path higher for equities despite the headwinds that have formed as a result of index divergence, geo-political risk, a stronger US dollar and any number of other challenges that have thrown the markets for a loop since September 18th.
Using recent economic data and Q2 corporate earnings as a guide post, seeing as how recent data has not appeared to disturb our macro-economic trends in any meaningful way, corporate America is positioned to deliver on record quarterly dividend payments to shareholders, record sales and expanding profit margins among other things.
Continue Reading
|
  |
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the "unsubscribe" link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks |
|
|
